Global Cell Therapy CDMO Services Market Research Report 2023
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cell Therapy CDMO Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
By Company
- Shanghai Medicilon Biopharmaceutical Co., Ltd.
- Puxin Biomedicine
- Porton Bio
- Lonza
- Catalent
- Oxford BioMedica
- and meta organisms
- GenScript
- Huakan Biology
- Cell Therapy CDMO
- Cell Therapy CRO
- Pharmaceutical Company
- Research Institute
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy CDMO Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cell Therapy CDMO
1.2.3 Cell Therapy CRO
1.3 Market by Application
1.3.1 Global Cell Therapy CDMO Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cell Therapy CDMO Services Market Perspective (2018-2029)
2.2 Cell Therapy CDMO Services Growth Trends by Region
2.2.1 Global Cell Therapy CDMO Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell Therapy CDMO Services Historic Market Size by Region (2018-2023)
2.2.3 Cell Therapy CDMO Services Forecasted Market Size by Region (2024-2029)
2.3 Cell Therapy CDMO Services Market Dynamics
2.3.1 Cell Therapy CDMO Services Industry Trends
2.3.2 Cell Therapy CDMO Services Market Drivers
2.3.3 Cell Therapy CDMO Services Market Challenges
2.3.4 Cell Therapy CDMO Services Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cell Therapy CDMO Services Players by Revenue
3.1.1 Global Top Cell Therapy CDMO Services Players by Revenue (2018-2023)
3.1.2 Global Cell Therapy CDMO Services Revenue Market Share by Players (2018-2023)
3.2 Global Cell Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Therapy CDMO Services Revenue
3.4 Global Cell Therapy CDMO Services Market Concentration Ratio
3.4.1 Global Cell Therapy CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy CDMO Services Revenue in 2022
3.5 Cell Therapy CDMO Services Key Players Head office and Area Served
3.6 Key Players Cell Therapy CDMO Services Product Solution and Service
3.7 Date of Enter into Cell Therapy CDMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CELL THERAPY CDMO SERVICES BREAKDOWN DATA BY TYPE
4.1 Global Cell Therapy CDMO Services Historic Market Size by Type (2018-2023)
4.2 Global Cell Therapy CDMO Services Forecasted Market Size by Type (2024-2029)
5 CELL THERAPY CDMO SERVICES BREAKDOWN DATA BY APPLICATION
5.1 Global Cell Therapy CDMO Services Historic Market Size by Application (2018-2023)
5.2 Global Cell Therapy CDMO Services Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cell Therapy CDMO Services Market Size (2018-2029)
6.2 North America Cell Therapy CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell Therapy CDMO Services Market Size by Country (2018-2023)
6.4 North America Cell Therapy CDMO Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Cell Therapy CDMO Services Market Size (2018-2029)
7.2 Europe Cell Therapy CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell Therapy CDMO Services Market Size by Country (2018-2023)
7.4 Europe Cell Therapy CDMO Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell Therapy CDMO Services Market Size (2018-2029)
8.2 Asia-Pacific Cell Therapy CDMO Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell Therapy CDMO Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell Therapy CDMO Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Cell Therapy CDMO Services Market Size (2018-2029)
9.2 Latin America Cell Therapy CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell Therapy CDMO Services Market Size by Country (2018-2023)
9.4 Latin America Cell Therapy CDMO Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell Therapy CDMO Services Market Size (2018-2029)
10.2 Middle East & Africa Cell Therapy CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Shanghai Medicilon Biopharmaceutical Co., Ltd.
11.1.1 Shanghai Medicilon Biopharmaceutical Co., Ltd. Company Detail
11.1.2 Shanghai Medicilon Biopharmaceutical Co., Ltd. Business Overview
11.1.3 Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Introduction
11.1.4 Shanghai Medicilon Biopharmaceutical Co., Ltd. Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.1.5 Shanghai Medicilon Biopharmaceutical Co., Ltd. Recent Development
11.2 Puxin Biomedicine
11.2.1 Puxin Biomedicine Company Detail
11.2.2 Puxin Biomedicine Business Overview
11.2.3 Puxin Biomedicine Cell Therapy CDMO Services Introduction
11.2.4 Puxin Biomedicine Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.2.5 Puxin Biomedicine Recent Development
11.3 Porton Bio
11.3.1 Porton Bio Company Detail
11.3.2 Porton Bio Business Overview
11.3.3 Porton Bio Cell Therapy CDMO Services Introduction
11.3.4 Porton Bio Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.3.5 Porton Bio Recent Development
11.4 Lonza
11.4.1 Lonza Company Detail
11.4.2 Lonza Business Overview
11.4.3 Lonza Cell Therapy CDMO Services Introduction
11.4.4 Lonza Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.4.5 Lonza Recent Development
11.5 Catalent
11.5.1 Catalent Company Detail
11.5.2 Catalent Business Overview
11.5.3 Catalent Cell Therapy CDMO Services Introduction
11.5.4 Catalent Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.5.5 Catalent Recent Development
11.6 Oxford BioMedica
11.6.1 Oxford BioMedica Company Detail
11.6.2 Oxford BioMedica Business Overview
11.6.3 Oxford BioMedica Cell Therapy CDMO Services Introduction
11.6.4 Oxford BioMedica Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.6.5 Oxford BioMedica Recent Development
11.7 and meta organisms
11.7.1 and meta organisms Company Detail
11.7.2 and meta organisms Business Overview
11.7.3 and meta organisms Cell Therapy CDMO Services Introduction
11.7.4 and meta organisms Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.7.5 and meta organisms Recent Development
11.8 GenScript
11.8.1 GenScript Company Detail
11.8.2 GenScript Business Overview
11.8.3 GenScript Cell Therapy CDMO Services Introduction
11.8.4 GenScript Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.8.5 GenScript Recent Development
11.9 Huakan Biology
11.9.1 Huakan Biology Company Detail
11.9.2 Huakan Biology Business Overview
11.9.3 Huakan Biology Cell Therapy CDMO Services Introduction
11.9.4 Huakan Biology Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.9.5 Huakan Biology Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy CDMO Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cell Therapy CDMO
1.2.3 Cell Therapy CRO
1.3 Market by Application
1.3.1 Global Cell Therapy CDMO Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cell Therapy CDMO Services Market Perspective (2018-2029)
2.2 Cell Therapy CDMO Services Growth Trends by Region
2.2.1 Global Cell Therapy CDMO Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell Therapy CDMO Services Historic Market Size by Region (2018-2023)
2.2.3 Cell Therapy CDMO Services Forecasted Market Size by Region (2024-2029)
2.3 Cell Therapy CDMO Services Market Dynamics
2.3.1 Cell Therapy CDMO Services Industry Trends
2.3.2 Cell Therapy CDMO Services Market Drivers
2.3.3 Cell Therapy CDMO Services Market Challenges
2.3.4 Cell Therapy CDMO Services Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cell Therapy CDMO Services Players by Revenue
3.1.1 Global Top Cell Therapy CDMO Services Players by Revenue (2018-2023)
3.1.2 Global Cell Therapy CDMO Services Revenue Market Share by Players (2018-2023)
3.2 Global Cell Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Therapy CDMO Services Revenue
3.4 Global Cell Therapy CDMO Services Market Concentration Ratio
3.4.1 Global Cell Therapy CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy CDMO Services Revenue in 2022
3.5 Cell Therapy CDMO Services Key Players Head office and Area Served
3.6 Key Players Cell Therapy CDMO Services Product Solution and Service
3.7 Date of Enter into Cell Therapy CDMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CELL THERAPY CDMO SERVICES BREAKDOWN DATA BY TYPE
4.1 Global Cell Therapy CDMO Services Historic Market Size by Type (2018-2023)
4.2 Global Cell Therapy CDMO Services Forecasted Market Size by Type (2024-2029)
5 CELL THERAPY CDMO SERVICES BREAKDOWN DATA BY APPLICATION
5.1 Global Cell Therapy CDMO Services Historic Market Size by Application (2018-2023)
5.2 Global Cell Therapy CDMO Services Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cell Therapy CDMO Services Market Size (2018-2029)
6.2 North America Cell Therapy CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell Therapy CDMO Services Market Size by Country (2018-2023)
6.4 North America Cell Therapy CDMO Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Cell Therapy CDMO Services Market Size (2018-2029)
7.2 Europe Cell Therapy CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell Therapy CDMO Services Market Size by Country (2018-2023)
7.4 Europe Cell Therapy CDMO Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell Therapy CDMO Services Market Size (2018-2029)
8.2 Asia-Pacific Cell Therapy CDMO Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell Therapy CDMO Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell Therapy CDMO Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Cell Therapy CDMO Services Market Size (2018-2029)
9.2 Latin America Cell Therapy CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell Therapy CDMO Services Market Size by Country (2018-2023)
9.4 Latin America Cell Therapy CDMO Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell Therapy CDMO Services Market Size (2018-2029)
10.2 Middle East & Africa Cell Therapy CDMO Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Shanghai Medicilon Biopharmaceutical Co., Ltd.
11.1.1 Shanghai Medicilon Biopharmaceutical Co., Ltd. Company Detail
11.1.2 Shanghai Medicilon Biopharmaceutical Co., Ltd. Business Overview
11.1.3 Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Introduction
11.1.4 Shanghai Medicilon Biopharmaceutical Co., Ltd. Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.1.5 Shanghai Medicilon Biopharmaceutical Co., Ltd. Recent Development
11.2 Puxin Biomedicine
11.2.1 Puxin Biomedicine Company Detail
11.2.2 Puxin Biomedicine Business Overview
11.2.3 Puxin Biomedicine Cell Therapy CDMO Services Introduction
11.2.4 Puxin Biomedicine Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.2.5 Puxin Biomedicine Recent Development
11.3 Porton Bio
11.3.1 Porton Bio Company Detail
11.3.2 Porton Bio Business Overview
11.3.3 Porton Bio Cell Therapy CDMO Services Introduction
11.3.4 Porton Bio Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.3.5 Porton Bio Recent Development
11.4 Lonza
11.4.1 Lonza Company Detail
11.4.2 Lonza Business Overview
11.4.3 Lonza Cell Therapy CDMO Services Introduction
11.4.4 Lonza Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.4.5 Lonza Recent Development
11.5 Catalent
11.5.1 Catalent Company Detail
11.5.2 Catalent Business Overview
11.5.3 Catalent Cell Therapy CDMO Services Introduction
11.5.4 Catalent Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.5.5 Catalent Recent Development
11.6 Oxford BioMedica
11.6.1 Oxford BioMedica Company Detail
11.6.2 Oxford BioMedica Business Overview
11.6.3 Oxford BioMedica Cell Therapy CDMO Services Introduction
11.6.4 Oxford BioMedica Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.6.5 Oxford BioMedica Recent Development
11.7 and meta organisms
11.7.1 and meta organisms Company Detail
11.7.2 and meta organisms Business Overview
11.7.3 and meta organisms Cell Therapy CDMO Services Introduction
11.7.4 and meta organisms Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.7.5 and meta organisms Recent Development
11.8 GenScript
11.8.1 GenScript Company Detail
11.8.2 GenScript Business Overview
11.8.3 GenScript Cell Therapy CDMO Services Introduction
11.8.4 GenScript Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.8.5 GenScript Recent Development
11.9 Huakan Biology
11.9.1 Huakan Biology Company Detail
11.9.2 Huakan Biology Business Overview
11.9.3 Huakan Biology Cell Therapy CDMO Services Introduction
11.9.4 Huakan Biology Revenue in Cell Therapy CDMO Services Business (2018-2023)
11.9.5 Huakan Biology Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Cell Therapy CDMO Services Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Cell Therapy CDMO
Table 3. Key Players of Cell Therapy CRO
Table 4. Global Cell Therapy CDMO Services Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Cell Therapy CDMO Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cell Therapy CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cell Therapy CDMO Services Market Share by Region (2018-2023)
Table 8. Global Cell Therapy CDMO Services Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Cell Therapy CDMO Services Market Share by Region (2024-2029)
Table 10. Cell Therapy CDMO Services Market Trends
Table 11. Cell Therapy CDMO Services Market Drivers
Table 12. Cell Therapy CDMO Services Market Challenges
Table 13. Cell Therapy CDMO Services Market Restraints
Table 14. Global Cell Therapy CDMO Services Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cell Therapy CDMO Services Market Share by Players (2018-2023)
Table 16. Global Top Cell Therapy CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO Services as of 2022)
Table 17. Ranking of Global Top Cell Therapy CDMO Services Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Cell Therapy CDMO Services Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cell Therapy CDMO Services Product Solution and Service
Table 21. Date of Enter into Cell Therapy CDMO Services Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cell Therapy CDMO Services Revenue Market Share by Type (2018-2023)
Table 25. Global Cell Therapy CDMO Services Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Cell Therapy CDMO Services Revenue Market Share by Type (2024-2029)
Table 27. Global Cell Therapy CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cell Therapy CDMO Services Revenue Market Share by Application (2018-2023)
Table 29. Global Cell Therapy CDMO Services Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Cell Therapy CDMO Services Revenue Market Share by Application (2024-2029)
Table 31. North America Cell Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Cell Therapy CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cell Therapy CDMO Services Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Cell Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Cell Therapy CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Cell Therapy CDMO Services Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Cell Therapy CDMO Services Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Cell Therapy CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Cell Therapy CDMO Services Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Cell Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Cell Therapy CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Cell Therapy CDMO Services Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Cell Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2024-2029) & (US$ Million)
Table 46. Shanghai Medicilon Biopharmaceutical Co., Ltd. Company Detail
Table 47. Shanghai Medicilon Biopharmaceutical Co., Ltd. Business Overview
Table 48. Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Product
Table 49. Shanghai Medicilon Biopharmaceutical Co., Ltd. Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 50. Shanghai Medicilon Biopharmaceutical Co., Ltd. Recent Development
Table 51. Puxin Biomedicine Company Detail
Table 52. Puxin Biomedicine Business Overview
Table 53. Puxin Biomedicine Cell Therapy CDMO Services Product
Table 54. Puxin Biomedicine Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 55. Puxin Biomedicine Recent Development
Table 56. Porton Bio Company Detail
Table 57. Porton Bio Business Overview
Table 58. Porton Bio Cell Therapy CDMO Services Product
Table 59. Porton Bio Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 60. Porton Bio Recent Development
Table 61. Lonza Company Detail
Table 62. Lonza Business Overview
Table 63. Lonza Cell Therapy CDMO Services Product
Table 64. Lonza Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 65. Lonza Recent Development
Table 66. Catalent Company Detail
Table 67. Catalent Business Overview
Table 68. Catalent Cell Therapy CDMO Services Product
Table 69. Catalent Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 70. Catalent Recent Development
Table 71. Oxford BioMedica Company Detail
Table 72. Oxford BioMedica Business Overview
Table 73. Oxford BioMedica Cell Therapy CDMO Services Product
Table 74. Oxford BioMedica Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 75. Oxford BioMedica Recent Development
Table 76. and meta organisms Company Detail
Table 77. and meta organisms Business Overview
Table 78. and meta organisms Cell Therapy CDMO Services Product
Table 79. and meta organisms Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 80. and meta organisms Recent Development
Table 81. GenScript Company Detail
Table 82. GenScript Business Overview
Table 83. GenScript Cell Therapy CDMO Services Product
Table 84. GenScript Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 85. GenScript Recent Development
Table 86. Huakan Biology Company Detail
Table 87. Huakan Biology Business Overview
Table 88. Huakan Biology Cell Therapy CDMO Services Product
Table 89. Huakan Biology Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 90. Huakan Biology Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 1. Global Cell Therapy CDMO Services Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Cell Therapy CDMO
Table 3. Key Players of Cell Therapy CRO
Table 4. Global Cell Therapy CDMO Services Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Cell Therapy CDMO Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cell Therapy CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cell Therapy CDMO Services Market Share by Region (2018-2023)
Table 8. Global Cell Therapy CDMO Services Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Cell Therapy CDMO Services Market Share by Region (2024-2029)
Table 10. Cell Therapy CDMO Services Market Trends
Table 11. Cell Therapy CDMO Services Market Drivers
Table 12. Cell Therapy CDMO Services Market Challenges
Table 13. Cell Therapy CDMO Services Market Restraints
Table 14. Global Cell Therapy CDMO Services Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cell Therapy CDMO Services Market Share by Players (2018-2023)
Table 16. Global Top Cell Therapy CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO Services as of 2022)
Table 17. Ranking of Global Top Cell Therapy CDMO Services Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Cell Therapy CDMO Services Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cell Therapy CDMO Services Product Solution and Service
Table 21. Date of Enter into Cell Therapy CDMO Services Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cell Therapy CDMO Services Revenue Market Share by Type (2018-2023)
Table 25. Global Cell Therapy CDMO Services Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Cell Therapy CDMO Services Revenue Market Share by Type (2024-2029)
Table 27. Global Cell Therapy CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cell Therapy CDMO Services Revenue Market Share by Application (2018-2023)
Table 29. Global Cell Therapy CDMO Services Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Cell Therapy CDMO Services Revenue Market Share by Application (2024-2029)
Table 31. North America Cell Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Cell Therapy CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cell Therapy CDMO Services Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Cell Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Cell Therapy CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Cell Therapy CDMO Services Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Cell Therapy CDMO Services Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Cell Therapy CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Cell Therapy CDMO Services Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Cell Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Cell Therapy CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Cell Therapy CDMO Services Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Cell Therapy CDMO Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2024-2029) & (US$ Million)
Table 46. Shanghai Medicilon Biopharmaceutical Co., Ltd. Company Detail
Table 47. Shanghai Medicilon Biopharmaceutical Co., Ltd. Business Overview
Table 48. Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Product
Table 49. Shanghai Medicilon Biopharmaceutical Co., Ltd. Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 50. Shanghai Medicilon Biopharmaceutical Co., Ltd. Recent Development
Table 51. Puxin Biomedicine Company Detail
Table 52. Puxin Biomedicine Business Overview
Table 53. Puxin Biomedicine Cell Therapy CDMO Services Product
Table 54. Puxin Biomedicine Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 55. Puxin Biomedicine Recent Development
Table 56. Porton Bio Company Detail
Table 57. Porton Bio Business Overview
Table 58. Porton Bio Cell Therapy CDMO Services Product
Table 59. Porton Bio Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 60. Porton Bio Recent Development
Table 61. Lonza Company Detail
Table 62. Lonza Business Overview
Table 63. Lonza Cell Therapy CDMO Services Product
Table 64. Lonza Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 65. Lonza Recent Development
Table 66. Catalent Company Detail
Table 67. Catalent Business Overview
Table 68. Catalent Cell Therapy CDMO Services Product
Table 69. Catalent Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 70. Catalent Recent Development
Table 71. Oxford BioMedica Company Detail
Table 72. Oxford BioMedica Business Overview
Table 73. Oxford BioMedica Cell Therapy CDMO Services Product
Table 74. Oxford BioMedica Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 75. Oxford BioMedica Recent Development
Table 76. and meta organisms Company Detail
Table 77. and meta organisms Business Overview
Table 78. and meta organisms Cell Therapy CDMO Services Product
Table 79. and meta organisms Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 80. and meta organisms Recent Development
Table 81. GenScript Company Detail
Table 82. GenScript Business Overview
Table 83. GenScript Cell Therapy CDMO Services Product
Table 84. GenScript Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 85. GenScript Recent Development
Table 86. Huakan Biology Company Detail
Table 87. Huakan Biology Business Overview
Table 88. Huakan Biology Cell Therapy CDMO Services Product
Table 89. Huakan Biology Revenue in Cell Therapy CDMO Services Business (2018-2023) & (US$ Million)
Table 90. Huakan Biology Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Cell Therapy CDMO Services Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cell Therapy CDMO Services Market Share by Type: 2022 VS 2029
Figure 3. Cell Therapy CDMO Features
Figure 4. Cell Therapy CRO Features
Figure 5. Global Cell Therapy CDMO Services Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Cell Therapy CDMO Services Market Share by Application: 2022 VS 2029
Figure 7. Pharmaceutical Company Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Cell Therapy CDMO Services Report Years Considered
Figure 10. Global Cell Therapy CDMO Services Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Cell Therapy CDMO Services Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Cell Therapy CDMO Services Market Share by Region: 2022 VS 2029
Figure 13. Global Cell Therapy CDMO Services Market Share by Players in 2022
Figure 14. Global Top Cell Therapy CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO Services as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Cell Therapy CDMO Services Revenue in 2022
Figure 16. North America Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Cell Therapy CDMO Services Market Share by Country (2018-2029)
Figure 18. United States Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Cell Therapy CDMO Services Market Share by Country (2018-2029)
Figure 22. Germany Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Cell Therapy CDMO Services Market Share by Region (2018-2029)
Figure 30. China Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Cell Therapy CDMO Services Market Share by Country (2018-2029)
Figure 38. Mexico Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Cell Therapy CDMO Services Market Share by Country (2018-2029)
Figure 42. Turkey Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Shanghai Medicilon Biopharmaceutical Co., Ltd. Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 45. Puxin Biomedicine Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 46. Porton Bio Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 47. Lonza Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 48. Catalent Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 49. Oxford BioMedica Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 50. and meta organisms Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 51. GenScript Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 52. Huakan Biology Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Figure 1. Global Cell Therapy CDMO Services Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cell Therapy CDMO Services Market Share by Type: 2022 VS 2029
Figure 3. Cell Therapy CDMO Features
Figure 4. Cell Therapy CRO Features
Figure 5. Global Cell Therapy CDMO Services Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Cell Therapy CDMO Services Market Share by Application: 2022 VS 2029
Figure 7. Pharmaceutical Company Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Cell Therapy CDMO Services Report Years Considered
Figure 10. Global Cell Therapy CDMO Services Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Cell Therapy CDMO Services Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Cell Therapy CDMO Services Market Share by Region: 2022 VS 2029
Figure 13. Global Cell Therapy CDMO Services Market Share by Players in 2022
Figure 14. Global Top Cell Therapy CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CDMO Services as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Cell Therapy CDMO Services Revenue in 2022
Figure 16. North America Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Cell Therapy CDMO Services Market Share by Country (2018-2029)
Figure 18. United States Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Cell Therapy CDMO Services Market Share by Country (2018-2029)
Figure 22. Germany Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Cell Therapy CDMO Services Market Share by Region (2018-2029)
Figure 30. China Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Cell Therapy CDMO Services Market Share by Country (2018-2029)
Figure 38. Mexico Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Cell Therapy CDMO Services Market Share by Country (2018-2029)
Figure 42. Turkey Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Cell Therapy CDMO Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Shanghai Medicilon Biopharmaceutical Co., Ltd. Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 45. Puxin Biomedicine Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 46. Porton Bio Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 47. Lonza Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 48. Catalent Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 49. Oxford BioMedica Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 50. and meta organisms Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 51. GenScript Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 52. Huakan Biology Revenue Growth Rate in Cell Therapy CDMO Services Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
